Exodus Se

Země: Nový Zéland

Jazyk: angličtina

Zdroj: Ministry for Primary Industries

Aktivní složka:

selenium present as sodium selenate; moxidectin

Dostupné s:

Boehringer Ingelheim Animal Health New Zealand Limited

INN (Mezinárodní Name):

selenium present as sodium selenate, moxidectin

Složení:

selenium present as sodium selenate 0.5 g/litre; moxidectin 1 g/litre

Terapeutické oblasti:

Endoparasiticide

Stav Autorizace:

ACVM Registered

Datum autorizace:

2008-01-09

Charakteristika produktu

Product : Exodus Se
Date: 7 Dec 2018
ACVM No.: A010018
Page 1 of 5
FRONT
WARNING
FOR ANIMAL TREATMENT ONLY
EXODUS
®
Se
Oral drench for the control & treatment of internal parasites and itch
mite in
sheep.
1 g/L MOXIDECTIN WITH 0.5 g/L SELENIUM.
NET CONTENTS: 1 LITRE / 5 LITRES / 10 LITRES / 20 LITRES / 50 LITRES
Please read label before use
Product : Exodus Se
Date: 7 Dec 2018
ACVM No.: A010018
Page 2 of 5
BACK
EXODUS SE
Contains 1 g/L moxidectin, a member of the macrocyclic lactones. Each
10 mL
dose contains 5 mg selenium.
It is effective against parasites in sheep sensitive to this family.
For the treatment
and control of the following mature and immature (*includes inhibited
L4.
_A _
adults
only) gastrointestinal and lungworm parasites: _Haemonchus
contortus*_,
_Trichostrongylus axei*, Trichostrongylus colubriformis*,
Trichostrongylus _
_vitrinus*, Ostertagia (Teladorsagia) circumcincta*, Ostertagia
trifurcata*, _
_Cooperia oncophora_
_A_
_, Cooperia curticei_
_A_
_, Cooperia punctata_
_A_
_, Nematodirus _
_spathiger*, Nematodirus filicollis*, Chabertia ovina*,
Oesophagostomum _
_venulosum_
_A_
_, Trichuris ovis_
_A_
_ _and_ Strongyloides papillosus_
_A_
_, Dictyocaulus filaria*. _
When used at the recommended dose rates, EXODUS Se prevents
reinfection
with _Haemonchus contortus_ for 35 days and _Ostertagia_
(_Teladorsagia) _
_circumcincta_ for at least 21 days following a single oral dose.
Also effective against itch mite (_Psorergates ovis_).
EXODUS Se is effective against gastrointestinal nematodes which are
resistant
to benzimidazole and levamisole/morantel anthelmintic action families.
It has also
shown efficacy against a number of strains of _Haemonchus contortus_
and
_Ostertagia_ spp. that are resistant to avermectins. Moxidectin shares
a similar
mechanism of action to the avermectins. It should not be used where
avermectin
resistance is present, except where specially recommended by an
adviser.
Resistance may develop to any anthelmintic. It is advisable that a
resistance test
be conducted regularly wh